Alpha Tau Medical Statistics
Total Valuation
DRTS has a market cap or net worth of $181.58 million. The enterprise value is $134.52 million.
Important Dates
The last earnings date was Wednesday, March 12, 2025, after market close.
| Earnings Date | Mar 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DRTS has 70.38 million shares outstanding. The number of shares has increased by 0.79% in one year.
| Current Share Class | 70.38M |
| Shares Outstanding | 70.38M |
| Shares Change (YoY) | +0.79% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 21.57% |
| Owned by Institutions (%) | 5.27% |
| Float | 52.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.90 |
| P/TBV Ratio | 2.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.40, with a Debt / Equity ratio of 0.20.
| Current Ratio | 7.40 |
| Quick Ratio | 6.91 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -118.95 |
Financial Efficiency
Return on equity (ROE) is -43.16% and return on invested capital (ROIC) is -26.05%.
| Return on Equity (ROE) | -43.16% |
| Return on Assets (ROA) | -23.27% |
| Return on Invested Capital (ROIC) | -26.05% |
| Return on Capital Employed (ROCE) | -46.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$254,000 |
| Employee Count | 125 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, DRTS has paid $6,000 in taxes.
| Income Tax | 6,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.03% in the last 52 weeks. The beta is 0.92, so DRTS's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -11.03% |
| 50-Day Moving Average | 3.01 |
| 200-Day Moving Average | 2.61 |
| Relative Strength Index (RSI) | 41.43 |
| Average Volume (20 Days) | 33,761 |
Short Selling Information
The latest short interest is 122,010, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 122,010 |
| Short Previous Month | 75,865 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.23% |
| Short Ratio (days to cover) | 1.86 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -36.04M |
| Pretax Income | -29.14M |
| Net Income | -31.75M |
| EBITDA | -34.94M |
| EBIT | -36.04M |
| Earnings Per Share (EPS) | -$0.45 |
Full Income StatementBalance Sheet
The company has $59.60 million in cash and $12.54 million in debt, giving a net cash position of $47.06 million or $0.67 per share.
| Cash & Cash Equivalents | 59.60M |
| Total Debt | 12.54M |
| Net Cash | 47.06M |
| Net Cash Per Share | $0.67 |
| Equity (Book Value) | 62.67M |
| Book Value Per Share | 0.89 |
| Working Capital | 55.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$19.78 million and capital expenditures -$2.24 million, giving a free cash flow of -$22.02 million.
| Operating Cash Flow | -19.78M |
| Capital Expenditures | -2.24M |
| Free Cash Flow | -22.02M |
| FCF Per Share | -$0.31 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |